Subscribe To Our Free Newsletter |
Lupin to sale trade generics biz to subsidiary on slump sale basis
Lupin said that its board has approved to carve out trade generics business in India to its wholly owned subsidiary, Lupin Life Sciences (LLSL) on a slump sale basis.